Artificial intelligence meets the world experts; updates and novel therapies in autoimmunity - The 14th international congress on autoimmunity 2024 (AUTO14), Ljubljana

被引:0
作者
Mahroum, Naim [1 ]
Elsalti, Abdulrahman [1 ]
Al Shawaf, Maisam [1 ]
Darkhabani, Mohammad [1 ]
Alwani, Abdulrahman [1 ]
Seida, Ravend [1 ]
Ertas, Muhammet Tayfur [1 ]
Simsek, Ayse Gulnihan [1 ]
Awad, Mustafa [1 ]
Habra, Mona [1 ]
Alrifaai, Mohamad Aosama [1 ]
Bogdanos, Dimitrios [2 ]
Shoenfeld, Yehuda [3 ,4 ]
机构
[1] Istanbul Medipol Univ, Int Sch Med, Istanbul, Turkiye
[2] Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Rheumatol & Clin Immunol, Larisa, Greece
[3] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Ramat Gan, Israel
[4] Reichman Univ, Herzliyya, Israel
关键词
Autoimmunity; Autoantibodies; AUTO14; Artificial intelligence; ChatGPT; CLASSIFICATION; VASCULITIS; ADJUVANTS; VACCINES; DISEASE; UVEITIS; SYSTEM;
D O I
10.1016/j.autrev.2024.103698
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The bi-annual international congress on autoimmunity is a huge opportunity for the medical community to discuss the latest updates in the field. During the 14th congress 2024 (AUTO14) in Ljubljana, artificial intelligence (AI) occupied special attention due to its recent and ongoing unequivocal role in various medical fields including autoimmunity. For instance, through a challenging debate between world-experts and the most popular AI bot used (ChatGPT), several clinical cases including a case of vasculitis were discussed in the plenary sessions. ChatGPT agreed with the clinical decisions made by the experts nevertheless, the bot added additional aspects related to the specific case. In this regard, ChatGPT emphasized the need for osteoporosis prophylaxis in a patient planned to be treated with systemic steroids for a long time. Furthermore, AUTO14 included the newest updates on most autoimmune disorders, distributed among tens of sessions. Among others, infection and auto- immunity, the sequalae of the pandemic of COVID-19, as well as COVID-19 vaccines were discussed as well. Due to the high numbers of the works presented, and for ensuring that important updates are not missed; we divided our paper into sections. The subtitles throughout the paper correspond to different sessions of the congress, all presenting new updates in the field. A figure aiding in navigating throughout the paper was also provided.
引用
收藏
页数:14
相关论文
共 129 条
  • [1] Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease
    Agardh, D.
    Matthias, T.
    Wusterhausen, P.
    Neidhoefer, S.
    Heller, A.
    Lerner, A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 199 (03) : 294 - 302
  • [2] Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype
    Ahmed, A. Razzaque
    Kalesinskas, Mikole
    Kooper-Johnson, Sarah
    [J]. AUTOIMMUNITY REVIEWS, 2023, 22 (10)
  • [3] International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft- versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges
    Alsultan, Abdulrahman
    Farge, Dominique
    Kili, Sven
    Forte, Miguel
    Weiss, Daniel J.
    Grignon, Felix
    Boelens, Jaap Jan
    [J]. CYTOTHERAPY, 2024, 26 (10) : 1132 - 1140
  • [4] Host-derived mannose glycans trigger a pathogenic?6 T cell/IL-17a axis in autoimmunity
    Alves, Ines
    Santos-Pereira, Beatriz
    de la Cruz, Noelia
    Campar, Ana
    Pinto, Vanda
    Rodrigues, Pedro M.
    Araujo, Marco
    Santos, Sofia
    Ramos-Soriano, Javier
    Vasconcelos, Carlos
    Silva, Roberto
    Afonso, Nuno
    Mira, Filipe
    Barrias, Cristina C.
    Alves, Nuno L.
    Rojo, Javier
    Santos, Lelita
    Marinho, Antonio
    Pinho, Salome S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (687)
  • [5] Andreoli L, 2024, RMD Open, V10
  • [6] Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy
    Antonelli, Alessandro
    Fallahi, Poupak
    Elia, Giusy
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Ruffilli, Ilaria
    Patrizio, Armando
    Gonnella, Debora
    Giusti, Claudia
    Virili, Camilla
    Centanni, Marco
    Shoenfeld, Yehuda
    Ferrari, Silvia Martina
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (01)
  • [7] EULAR/ACR classification criteria for SLE
    Aringer, Martin
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 : S14 - S17
  • [8] Complement as a Biomarker for Systemic Lupus Erythematosus
    Ayano, Masahiro
    Horiuchi, Takahiko
    [J]. BIOMOLECULES, 2023, 13 (02)
  • [9] 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
    Barbhaiya, Medha
    Zuily, Stephane
    Naden, Ray
    Hendry, Alison
    Manneville, Florian
    Amigo, Mary-Carmen
    Amoura, Zahir
    Andrade, Danieli
    Andreoli, Laura
    Artim-Esen, Bahar
    Atsumi, Tatsuya
    Avcin, Tadej
    Belmont, Michael H.
    Bertolaccini, Maria Laura
    Branch, D. Ware
    Carvalheiras, Graziela
    Casini, Alessandro
    Cervera, Ricard
    Cohen, Hannah
    Costedoat-Chalumeau, Nathalie
    Crowther, Mark
    de Jesus, Guilherme
    Delluc, Aurelien
    Desai, Sheetal
    De Sancho, Maria
    Devreese, Katrien M.
    Diz-Kucukkaya, Reyhan
    Duarte-Garcia, Ali
    Frances, Camille
    Garcia, David
    Gris, Jean-Christophe
    Jordan, Natasha
    Leaf, Rebecca K.
    Kello, Nina
    Knight, Jason S.
    Laskin, Carl
    Lee, Alfred, I
    Legault, Kimberly
    Levine, Steve R.
    Levy, Roger A.
    Limper, Maarten
    Lockshin, Michael D.
    Mayer-Pickel, Karoline
    Musial, Jack
    Meroni, Pier Luigi
    Orsolini, Giovanni
    Ortel, Thomas L.
    Pengo, Vittorio
    Petri, Michelle
    Pons-Estel, Guillermo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 (10) : 1687 - 1702
  • [10] 2023 ACR/EULAR antiphospholipid syndrome classification criteria
    Barbhaiya, Medha
    Zuily, Stephane
    Naden, Ray
    Hendry, Alison
    Manneville, Florian
    Amigo, Mary-Carmen
    Amoura, Zahir
    Andrade, Danieli
    Andreoli, Laura
    Artim-Esen, Bahar
    Atsumi, Tatsuya
    Avcin, Tadej
    Belmont, Michael H.
    Bertolaccini, Maria Laura
    Branch, D. Ware
    Carvalheiras, Graziela
    Casini, Alessandro
    Cervera, Ricard
    Cohen, Hannah
    Costedoat-Chalumeau, Nathalie
    Crowther, Mark
    de Jesus, Guilherme
    Delluc, Aurelien
    Desai, Sheetal
    De Sancho, Maria
    Devreese, Katrien M.
    Diz-Kucukkaya, Reyhan
    Duarte-Garcia, Ali
    Frances, Camille
    Garcia, David
    Gris, Jean-Christophe
    Jordan, Natasha
    Leaf, Rebecca K.
    Kello, Nina
    Knight, Jason S.
    Laskin, Carl
    Lee, Alfred I.
    Legault, Kimberly
    Levine, Steve R.
    Levy, Roger A.
    Limper, Maarten
    Lockshin, Michael D.
    Mayer-Pickel, Karoline
    Musial, Jack
    Meroni, Pier Luigi
    Orsolini, Giovanni
    Ortel, Thomas L.
    Pengo, Vittorio
    Petri, Michelle
    Pons-Estel, Guillermo
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1258 - 1270